FDA widens approval for Endologix's aneurysm repair device

04/18/2013 | Healio

The FDA has granted Endologix expanded approval for its AFX endovascular system used to treat abdominal aortic aneurysms, along with the company's IntuiTrak Powerlink technology. The device is now approved for use in percutaneous endovascular aneurysm repair procedures and could be available for physician training in the U.S. as early as the second quarter.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX